Dear Dirty America

DDA

The Mercky Statement About Gardasil

September 24
04:41 2011
Jan Christian

Straight from the mouth of Merck:

The facts about GARDASIL are clear. The efficacy and safety of GARDASIL was established in clinical trials in thousands of patients. Since its approval in 2006, the vaccine has been given to millions of girls around the world. Merck remains strongly committed to preventing cervical cancer.
Leading national and international health organizations actively monitor and evaluate the HPV vaccine, and they continue to recommend its use. Just last month, the Institute of Medicine reaffirmed the safety of a number of vaccines, including HPV vaccines, and concluded, “Despite much media attention and strong opinions from many quarters, vaccines remain one of the greatest tools in the public health arsenal.”
Every year, approximately 12,000 women in the United States are diagnosed with cervical cancer, and most cases are caused by HPV types 16 and 18. This is why the medical community rejoiced when HPV vaccines first become widely available in 2006, and why Merck continues in its efforts to prevent cervical cancer.
GARDASIL is approved for use in girls and young women 9 through 26 years of age for the prevention of cervical, vulvar, vaginal and anal cancers caused by HPV types 16 and 18; genital warts caused by HPV types 6 and 11; and precancerous or dysplastic lesions caused by HPV types 6, 11, 16 and 18.

Related Articles

0 Comments

No Comments Yet!

There are no comments at the moment, do you want to add one?

Write a comment

Write a Comment

Leave a Reply

Subscribe

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Dear Dirty America Copyright

© Dear Dirty America, 2011-2017. Unauthorized use and/or duplication of this material without express and written permission from this blog’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Dear Dirty America with appropriate and specific direction to the original content.